Vadadustat treatment for lung injury from infection
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests a pill called vadadustat for people with a serious lung condition called ARDS, which makes it hard to breathe. The drug may reduce inflammation and improve oxygen levels, helping patients recover without needing a breathing tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lung injury caused by an infection like pneumonia or another infection in the body.
- You have low oxygen levels despite using a high-flow oxygen mask or a breathing machine (but not a breathing tube).
- Your breathing problem started or got worse within the last week.
- Your chest X-ray or ultrasound shows new fluid or inflammation in the lungs.
- You are not currently on medications that could interfere, and you have no serious liver or blood problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This study tests an experimental drug (STSA-1002) for people with severe breathing problems caused by a viral infection. It aims to see if the drug can help improve oxygen levels and reduce the need for a breathing machine.
This trial tests a combination of two medicines (Sivelestat Sodium and Dexamethasone) to see if they can help people with severe lung injury (ARDS) who need a breathing machine. It is for patients whose condition has just worsened and who are on a ventilator early in their illness.
This pilot study tests NOA-001, a treatment given to people with ARDS (a serious lung condition) who are already on a breathing machine. It looks at whether the treatment can improve outcomes in ARDS caused by either non-COVID illnesses or COVID-19.
This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.
This trial tests two medicines, simvastatin and baricitinib, to see if they can help people with severe breathing problems in the hospital. The goal is to find which medicine works best for each patient, possibly improving their recovery.
Hear when a new Nonintubated Acute Respiratory Distress Syndrome (ARDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.